Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
CC transcript
Inv. presentation

Jazz Pharmaceuticals plc (JAZZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2023 4 ORiordan Anne (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.158, valued at $171.5k
08/15/2023 4 O'Keefe Kenneth W (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1585, valued at $171.5k
08/15/2023 4 Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1584, valued at $171.5k
08/15/2023 4 Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1585, valued at $171.5k
08/15/2023 4 Smith Mark Douglas (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1579, valued at $171.5k
08/15/2023 4 RIEDEL NORBERT G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1581, valued at $171.5k
08/15/2023 4 Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
08/15/2023 4 McSharry Heather Ann (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,344 shares @ $138.1586, valued at $185.7k
08/15/2023 4 Henderson Mary Elizabeth (SVP, Technical Operations) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 10,763 shares @ $0
08/15/2023 4 Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1584, valued at $171.5k
08/15/2023 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1585, valued at $171.5k
08/15/2023 4 Cook Jennifer E. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1581, valued at $171.5k
08/15/2023 4 Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 158 shares @ $138.1575, valued at $21.8k
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 3 Henderson Mary Elizabeth (SVP, Technical Operations) has filed a Form 3 on Jazz Pharmaceuticals plc
08/09/2023 4 Patil Neena M (EVP & Chief Legal Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Disposed/sold 1,390 shares @ $131.51, valued at $182.8k
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance – Strong execution delivered second quarter 2023 total revenues of $957 million –"
07/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/16/2023 ARS Form ARS - Annual Report to Security Holders:
06/16/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/16/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy